Federated Hermes Inc. Raises Stock Holdings in American Healthcare REIT, Inc. (NYSE:AHR)

Key Points

• Federated Hermes Inc. increased its holdings in American Healthcare REIT by 3.0%, now owning approximately 0.42% of the company, valued at over $20 million.
• American Healthcare REIT reported earnings of $0.38 per share for the last quarter, beating expectations and showing an 8.2% year-over-year revenue increase.
• The company recently declared a quarterly dividend of $0.25 per share, with a 2.6% dividend yield, despite a negative payout ratio of -370.37%.

Federated Hermes Inc. boosted its holdings in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 3.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 663,800 shares of the company's stock after purchasing an additional 19,070 shares during the period. Federated Hermes Inc. owned about 0.42% of American Healthcare REIT worth $20,113,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Wolff Wiese Magana LLC purchased a new position in shares of American Healthcare REIT in the 1st quarter worth about $25,000. MassMutual Private Wealth & Trust FSB raised its position in American Healthcare REIT by 189.0% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 968 shares of the company's stock worth $29,000 after acquiring an additional 633 shares during the period. Spirit of America Management Corp NY bought a new stake in American Healthcare REIT in the first quarter worth about $30,000. Continuum Advisory LLC purchased a new position in American Healthcare REIT in the first quarter valued at about $37,000. Finally, Tsfg LLC bought a new position in shares of American Healthcare REIT during the 1st quarter valued at approximately $41,000. Institutional investors own 16.68% of the company's stock.

Insider Activity at American Healthcare REIT

In related news, CIO Stefan K.L. Oh sold 3,860 shares of the stock in a transaction on Monday, June 30th. The stock was sold at an average price of $36.10, for a total value of $139,346.00. Following the sale, the executive owned 95,671 shares in the company, valued at approximately $3,453,723.10. This trade represents a 3.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.92% of the stock is owned by company insiders.

American Healthcare REIT Stock Performance

Shares of AHR opened at $38.67 on Friday. American Healthcare REIT, Inc. has a 52-week low of $14.79 and a 52-week high of $39.06. The stock's 50-day simple moving average is $36.26 and its 200 day simple moving average is $32.18. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.38 and a current ratio of 0.38. The stock has a market capitalization of $6.17 billion, a price-to-earnings ratio of -143.23, a price-to-earnings-growth ratio of 2.14 and a beta of 1.09.

American Healthcare REIT (NYSE:AHR - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.01. American Healthcare REIT had a negative return on equity of 1.85% and a negative net margin of 1.96%. The firm had revenue of $540.60 million for the quarter, compared to analysts' expectations of $542.32 million. During the same period in the prior year, the business posted $0.30 earnings per share. The company's revenue was up 8.2% on a year-over-year basis. Research analysts forecast that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, July 18th. Stockholders of record on Monday, June 30th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date was Monday, June 30th. American Healthcare REIT's payout ratio is -370.37%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on AHR shares. KeyCorp lifted their price target on shares of American Healthcare REIT from $34.00 to $40.00 and gave the stock an "overweight" rating in a report on Wednesday, June 11th. Baird R W upgraded American Healthcare REIT to a "strong-buy" rating in a research note on Thursday, July 17th. Morgan Stanley upped their price target on American Healthcare REIT from $37.00 to $45.00 and gave the company an "overweight" rating in a research report on Tuesday, May 20th. Jefferies Financial Group initiated coverage on American Healthcare REIT in a research note on Monday, April 28th. They set a "buy" rating and a $37.00 price target for the company. Finally, Truist Financial boosted their price objective on American Healthcare REIT from $32.00 to $38.00 and gave the company a "buy" rating in a research note on Monday, June 9th. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $38.11.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.